Effector T cells immune reactivity among patients with acute hepatitis e

Journal of Viral Hepatitis

Volumn 18, Issue 10, 2011, Pages

  Husain, M M ^a   Aggarwal, R ^a   Kumar, D ^a   Jameel, S ^b   Naik, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

CD4 cells; CD4 +CD8 + double positive cells; CD8 cells; cellular immune responses; ELISPOT assays; gamma interferon; hepatitis E; T cells

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS E; HUMAN; INTERFERON PRODUCTION; MALE; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; EPITOPES; FEMALE; FLOW CYTOMETRY; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INTERFERON-GAMMA; MALE; T-LYMPHOCYTE SUBSETS; VIRAL PROTEINS;

EID: 80052834449     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01489.x     Document Type: Article

References (22)

1. Aggarwal R, Naik S,. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009; 24: 1484-1493.
2. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI,. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981; 70: 252-255. (Pubitemid 11146007)
3. Chandra V, Taneja S, Kalia M, Jameel S,. Molecular biology and pathogenesis of hepatitis E virus. J Biosci 2008; 33: 451-464.
4. Vallbracht A, Gabriel P, Maier K, et al. Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology 1986; 6: 1308-1314. (Pubitemid 17210559)
5. Rehermann B, Nascimbeni M,. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229. (Pubitemid 40364823)
6. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S,. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat 2008; 15: 910-916.
7. Aggarwal R, Shukla R, Jameel S, et al. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat 2007; 14: 283-292. (Pubitemid 46452413)
8. Srivastava R, Aggarwal R, Jameel S, et al. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 2007; 20: 56-65. (Pubitemid 46608952)
9. Zafrullah M, Khursheed Z, Yadav S, Sahgal D, Jameel S, Ahmad F,. Acidic pH enhances structure and structural stability of the capsid protein of hepatitis E virus. Biochem Biophys Res Commun 2004; 313: 67-73. (Pubitemid 37524026)
10. Panda SK, Nanda SK, Zafrullah M, Ansari IH, Ozdener MH, Jameel S,. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J Clin Microbiol 1995; 33: 2653-2659.
11. Parel Y, Chizzolini C,. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev 2004; 3: 215-220. (Pubitemid 38521097)
12. Suni MA, Ghanekar SA, Houck DW, et al. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur J Immunol 2001; 31: 2512-2520. (Pubitemid 32785371)
13. + double-positive T cells in early and chronic HIV-1 infection. J Acquir Immune Defic Syndr 2009; 50: 444-456.
14. Wu T, Zhang J, Su ZJ, et al. Specific cellular immune response in hepatitis E patients. Intervirology 2008; 51: 322-327.
15. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994; 91: 10198-10202. (Pubitemid 24311976)
16. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903. (Pubitemid 46339908)
17. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23: 2893-2901. (Pubitemid 40386491)
18. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
19. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-817. (Pubitemid 351281642)
20. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC,. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25: 449-458. (Pubitemid 27069071)
21. Urbani S, Amadei B, Fisicaro P, et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006; 44: 126-139. (Pubitemid 44049146)
22. Fitzmaurice K, Klenerman P,. Cellular immunity and acute hepatitis C infection. Curr Pharm Des 2008; 14: 1666-1677. (Pubitemid 351998591)